RxDoctor Payments Data

Phyllis Skolnik, MD

Procedural Dermatology · Miami, FLNPI 1023081692

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations.

$2,695in general payments, 2019–2025

Across 79 payments — averaging $34.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$492
  • Pfizer$421
  • AbbVie$399
  • Incyte Corporation$324
  • UCB, Inc.$235
  • Novartis$130
  • plus $693 from 18 others

What the payments were for

  • Food & beverage$2,695100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,695 in reported general payments places this provider in the 60th percentile of 60 procedural dermatology providers in Florida.

See all procedural dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$61,984
Medicare patients
123
Services billed
676

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin1,393$18,278
Metronidazole274$12,762
Ciclopirox159$5,482
Ketoconazole371$5,160
Mometasone Furoate273$4,174
Azelaic Acid21$3,516
Clobetasol Propionate88$3,004
Ammonium Lactate157$2,583
SsdSilver Sulfadiazine155$2,353
Doxycycline Hyclate223$1,676
Betamethasone Dipropionate28$1,443
Tacrolimus13$1,304
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc26$1,276
Nystatin67$798
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav123$746

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →